{"entity":{"type":"insider","cik":"0001511365","url":"/insider/0001511365","json_url":"/insider/0001511365.json","name":"Palmer Pamela P","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":6,"first":"2011-06-13","last":"2023-08-25","span_basis":"filed_date"},"name_variants":[{"name":"Palmer Pamela P","source":"filing","n_filings":6,"first_seen":"2011-06-13","last_seen":"2023-08-25"}],"transactions":[{"id":8630216,"accession":"0001209191-23-047348","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-047348","line_url":"/filing/0001209191-23-047348#line-2","is_derivative":false,"issuer_cik":"0001427925","issuer_name":"ACELRX PHARMACEUTICALS INC","issuer_ticker":"ACRX","issuer_name_source":null,"issuer_url":"/issuer/0001427925","owner_cik":"0001511365","owner_name":"Palmer Pamela P","owner_url":"/insider/0001511365","role":"Director, Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7442.0,"shares_display":"7,442","price_per_share":1.089,"price_display":"1.09","price_state":"stated","total_value":8104.338,"total_display":"8,104.34","shares_owned_after":30753.0,"shares_owned_after_display":"30,753","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-25","filed_date":"2023-08-25","scope":"insider"},{"id":8630212,"accession":"0001209191-23-047348","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-047348","line_url":"/filing/0001209191-23-047348#line-1","is_derivative":false,"issuer_cik":"0001427925","issuer_name":"ACELRX PHARMACEUTICALS INC","issuer_ticker":"ACRX","issuer_name_source":null,"issuer_url":"/issuer/0001427925","owner_cik":"0001511365","owner_name":"Palmer Pamela P","owner_url":"/insider/0001511365","role":"Director, Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9514.0,"shares_display":"9,514","price_per_share":1.17,"price_display":"1.17","price_state":"stated","total_value":11131.38,"total_display":"11,131.38","shares_owned_after":38195.0,"shares_owned_after_display":"38,195","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-24","filed_date":"2023-08-25","scope":"insider"},{"id":8343140,"accession":"0001209191-19-015612","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-015612","line_url":"/filing/0001209191-19-015612#line-1","is_derivative":false,"issuer_cik":"0001427925","issuer_name":"ACELRX PHARMACEUTICALS INC","issuer_ticker":"ACRX","issuer_name_source":null,"issuer_url":"/issuer/0001427925","owner_cik":"0001511365","owner_name":"Palmer Pamela P","owner_url":"/insider/0001511365","role":"Director, Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":840.0,"shares_display":"840","price_per_share":2.81,"price_display":"2.81","price_state":"stated","total_value":2360.4,"total_display":"2,360.40","shares_owned_after":541724.0,"shares_owned_after_display":"541,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-28","filed_date":"2019-03-04","scope":"insider"},{"id":6914014,"accession":"0001209191-18-059292","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-059292","line_url":"/filing/0001209191-18-059292#line-1","is_derivative":false,"issuer_cik":"0001427925","issuer_name":"ACELRX PHARMACEUTICALS INC","issuer_ticker":"ACRX","issuer_name_source":null,"issuer_url":"/issuer/0001427925","owner_cik":"0001511365","owner_name":"Palmer Pamela P","owner_url":"/insider/0001511365","role":"Director, Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16000.0,"shares_display":"16,000","price_per_share":3.07,"price_display":"3.07","price_state":"stated","total_value":49120.0,"total_display":"49,120.00","shares_owned_after":472134.0,"shares_owned_after_display":"472,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-19","filed_date":"2018-11-19","scope":"insider"},{"id":6707181,"accession":"0001209191-18-045581","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-045581","line_url":"/filing/0001209191-18-045581#line-1","is_derivative":false,"issuer_cik":"0001427925","issuer_name":"ACELRX PHARMACEUTICALS INC","issuer_ticker":"ACRX","issuer_name_source":null,"issuer_url":"/issuer/0001427925","owner_cik":"0001511365","owner_name":"Palmer Pamela P","owner_url":"/insider/0001511365","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":37000.0,"shares_display":"37,000","price_per_share":2.75,"price_display":"2.75","price_state":"stated","total_value":101750.0,"total_display":"101,750.00","shares_owned_after":456134.0,"shares_owned_after_display":"456,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-06","filed_date":"2018-08-06","scope":"insider"},{"id":5333525,"accession":"0001437749-17-015179","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-17-015179","line_url":"/filing/0001437749-17-015179#line-1","is_derivative":false,"issuer_cik":"0001427925","issuer_name":"ACELRX PHARMACEUTICALS INC","issuer_ticker":"ACRX","issuer_name_source":null,"issuer_url":"/issuer/0001427925","owner_cik":"0001511365","owner_name":"Palmer Pamela P","owner_url":"/insider/0001511365","role":"Director, Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.9487,"price_display":"2.95","price_state":"stated","total_value":29487.0,"total_display":"29,487.00","shares_owned_after":415801.0,"shares_owned_after_display":"415,801","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-22","filed_date":"2017-08-22","scope":"insider"},{"id":8864931,"accession":"0001181431-11-036390","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-036390","line_url":"/filing/0001181431-11-036390#line-1","is_derivative":false,"issuer_cik":"0001427925","issuer_name":"ACELRX PHARMACEUTICALS INC","issuer_ticker":"ACRX","issuer_name_source":null,"issuer_url":"/issuer/0001427925","owner_cik":"0001511365","owner_name":"Palmer Pamela P","owner_url":"/insider/0001511365","role":"Director, Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8800.0,"shares_display":"8,800","price_per_share":4.61,"price_display":"4.61","price_state":"stated","total_value":40568.0,"total_display":"40,568.00","shares_owned_after":326394.0,"shares_owned_after_display":"326,394","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-09","filed_date":"2011-06-13","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001427925","name":"ACELRX PHARMACEUTICALS INC","url":"/issuer/0001427925","role":"Director, Officer (Chief Medical Officer)","n_filings":6,"first_seen":"2011-06-13","last_seen":"2023-08-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001511365","retrieved_at":"2026-08-21T18:13:48+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}